19937 results for «»
19937 results
Percutaneous coronary intervention for bifurcation coronary lesions using optimised angiographic guidance: the 18th Consensus Document from the European Bifurcation Club
24 Jun 2024
In coronary bifurcation lesions (CBL) PCI, intracoronary imaging (ICI) is preferred for its superior outcomes over angiography alone, but its adoption is limited by education and technology access barriers, resulting in most CBL PCIs still using angiographic guidance only.
Reviewer
Reviewer
First-in-human data for Sensome clot-sensing guidewire used in ischemic stroke treatment demonstrate ability to automate clot characterization with no safety issues
05 Jun 2024
First-in-human experience with EasyCross: a novel catheter for a safe and correct aortic valve crossing
14 Jun 2024
This EIJ image highlights a new device designed to enhance the safety and efficiency of ViV TAVI procedures, particularly TAV-in-TAV, by reducing attempts to cross the valve and preventing guidewire misnavigation, thereby minimizing complications and procedure time.
New York Valves 2024: Everything you need to know in a nutshell
11 Jun 2024
Alex Sticchi provides his take on the trials which were presented at New York Valves 2024, offering a concise summary, a short description and final thoughts.
Author
PCR Tricuspid Focus Group - referral meeting in Kiel
26 Jul 2024
Join your peers for this meeting on 11 October 2024 in Kiel, Germany!
The LANDMARK RCT: key findings and relevance in clinical practice
15 May 2024 – From EuroPCR 2024
Join Patrick Serruys, Niels Van Royen, and Andreas Baumbach in a roundtable discussing the LANDMARK RCT trial, a randomized comparison of three valves aiming to validate the Myval balloon-expandable THV. Explore the trial's methodology, clinical outcomes, and findings on this new intermediate-size device, which offers adaptability...
Matthias Petersen
Kiel, Germany
Johanne Frank
Kiel, Germany
Intravascular ultrasound vs angiography-guided drug-coated balloon angioplasty: the ULTIMATE III trial
13 Jun 2024
The results of this study show that IVUS guidance is associated with less late lumen loss compared to angiography guidance in HBR patients undergoing DCB angioplasty.
Reviewer
PCR Tricuspid Focus Group - referral meeting in Bonn
13 Jun 2024
Join your peers for this meeting on 24 January 2025 in Bonn, Germany!
A review of the 2024 ESC Guidelines on elevated blood pressure and hypertension
13 Nov 2024
Lucas Lauder and Felix Mahfoud provide a summary of the ESC Guidelines on elevated blood pressure and hypertension presented by John William McEvoy and Rhian Touyz at ESC Congress 2024 in London.
Author
Author
MitrAI score: machine learning models to predict mortality at 12, 24, 36 and 48 months in patients with primary and secondary MR treated by TEER
31 Aug 2024
Jonathan Curio provides his take on the MitrAI score study which was presented by Luigi Biasco at ESC Congress 2024 in London.
Author
How to perform safe and effective renal denervation
20 Sep 2024
Following the recent inclusion of renal denervation as an approved therapy in the 2023 European Society of Hypertension guidelines, Andrew Sharp and Felix Mahfoud discuss patient selection (for those with resistant hypertension or uncontrolled blood pressure), setting up best practices, the safe and appropriate use of contrast, choosing...
The Essentials
17 Jun 2024
An in-depth educational report for peer-to-peer learning
The Essentials is an editorial initiative designed to elevate peer-to-peer learning in interventional cardiology. Each report, led by a renowned Medical Leader, gathers insights from 4 to 5 expert authors, offering original content on crucial, cutting-edge topics. The Essentials delivers...
Andreas Grüntzig Ethica Award ceremony
15 May 2024 – From EuroPCR 2024
This session is the Andreas Grüntzig Ethica Award ceremony.
Hypertension - the silver bullet of medicine
24 Sep 2024
In this Special Report, we describe how to safely integrate the latest additional guideline-recommended treatment option for some hypertensive patients - renal denervation.
Leading innovation for patients with valvular heart disease
24 Nov 2024 – From PCR London Valves 2024
Discover the newest advancements in transcatheter heart valves and their role in modern lifetime management of valvular heart disease. Review the latest clinical outcomes demonstrating improved patient care and explore how a diverse device portfolio addresses a wide range of valve anatomies.
Rendez-vous with Myval THV series and Landmark RCT subset analysis
24 Nov 2024 – From PCR London Valves 2024
Discover this interactive session during which the audience learns about and discusses the novel Myval THV Series, a series of valves featuring intermediate and XL sizes. They also discuss the results of the pivotal LANDMARK randomized controlled trial and its relevance in clinical practice.
Optimisation of your valve implantation to ensure lifelong outcomes using a novel self-expanding valve
24 Nov 2024 – From PCR London Valves 2024
Gain insights into the importance of valve optimization post-implantation to secure acute and long-term outcomes. In this session, you will discover the new features and benefits of the ACURATE Prime platform illustrated by a recorded case, and compare how different TAVI platforms perform when treating larger...
Optimising TAVI for bicuspid aortic stenosis: experience with a novel self-expanding system
26 Nov 2024 – From PCR London Valves 2024
Watch this session to explore the latest trial results and insights on treating bicuspid aortic stenosis with self-expanding valves. Learn key tips for optimal outcomes, including the importance of supra-annular assessment, appropriate sizing, and techniques to prevent underexpansion. Discover the VitaFlow specifications and clinical data, including...
